123 related articles for article (PubMed ID: 33975722)
1. [Is preoperative axillary radio-cytology justified after ACOSOG Z001?].
Defer A; Tessier V; Haudebourg J; Dejode M; Gosset M; Barranger E; Delpech Y
Bull Cancer; 2021 Jun; 108(6):605-613. PubMed ID: 33975722
[TBL] [Abstract][Full Text] [Related]
2. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
Liang Y; Chen X; Tong Y; Zhan W; Zhu Y; Wu J; Huang O; He J; Zhu L; Li Y; Chen W; Shen K
World J Surg Oncol; 2019 Feb; 17(1):37. PubMed ID: 30786903
[TBL] [Abstract][Full Text] [Related]
3. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
4. Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment?
Liberale V; Rosso R; Arisio R; D'Alonzo M; Villasco A; Fuso L; De Sanctis C; Modaffari P; Biglia N
Breast J; 2020 Feb; 26(2):168-175. PubMed ID: 31448500
[TBL] [Abstract][Full Text] [Related]
5. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
7. Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.
Riedel F; Heil J; Feißt M; Rezai M; Moderow M; Sohn C; Schütz F; Golatta M; Hennigs A
Breast Cancer Res Treat; 2019 Sep; 177(2):457-467. PubMed ID: 31236814
[TBL] [Abstract][Full Text] [Related]
8. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
9. The impact of axillary ultrasound with biopsy in overtreatment of early breast cancer.
Del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
Eur J Radiol; 2018 Jan; 98():158-164. PubMed ID: 29279156
[TBL] [Abstract][Full Text] [Related]
10. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
Mathias BJ; Sun J; Sun W; Zhou JM; Fulp WJ; Laronga C; Lee MC; Kiluk JV
Clin Breast Cancer; 2021 Feb; 21(1):74-79. PubMed ID: 32917535
[TBL] [Abstract][Full Text] [Related]
11. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
[TBL] [Abstract][Full Text] [Related]
12. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
[TBL] [Abstract][Full Text] [Related]
13. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
Lim GH; Upadhyaya VS; Acosta HA; Lim JMA; Allen JC; Leong LCH
Eur J Surg Oncol; 2018 Jul; 44(7):945-950. PubMed ID: 29705286
[TBL] [Abstract][Full Text] [Related]
14. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
[TBL] [Abstract][Full Text] [Related]
15. [Strategies in case of metastatic sentinel lymph node in breast cancer].
Costaz H; Rouffiac M; Boulle D; Arnould L; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Vincent L; Jankowski C; Coutant C
Bull Cancer; 2020 Jun; 107(6):672-685. PubMed ID: 31699399
[TBL] [Abstract][Full Text] [Related]
16. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
[TBL] [Abstract][Full Text] [Related]
17. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic de-escalation in breast cancer surgery].
Bodet ML; Roosen A; Hequet D; Rouzier R
Bull Cancer; 2021 Dec; 108(12):1145-1154. PubMed ID: 34656300
[TBL] [Abstract][Full Text] [Related]
19. Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes.
Cipolla C; Valerio MR; Grassi N; Calamia S; Latteri S; Latteri M; Graceffa G; Vieni S
In Vivo; 2020; 34(2):729-734. PubMed ID: 32111777
[TBL] [Abstract][Full Text] [Related]
20. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]